NEWARK, Calif. — Ultima Genomics, Inc. (the Company) has signed an agreement with Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) to further advance Ultima Genomics’ sequencing architecture. Under the terms of the agreement, Regeneron will collaborate with Ultima on the development and testing of Ultima’s second-generation sequencing platform, which will build upon the advances of the Company’s first […]
EMERYVILLE, Calif. — SLINGSHOT BIOSCIENCES, INC. the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with OLS – OMNI Life Science. OLS is your partner for solutions in Flow Cytometry, Cell Culture, Cell Counting, Imaging, and Cell Analysis. We offer innovative systems for the entire workflow of […]
DKSH has further expanded its distribution agreement with Bruker AXS in China to also cover Bruker’s benchtop Wavelength Dispersive X-Ray Fluorescence (WDXRF) product portfolio for accurate determination of elemental concentrations. Shanghai, China – DKSH Business Unit Technology and Bruker AXS, renowned for its market-leading analytical X-ray solutions, have further expanded their partnership in China. DKSH […]
EMERYVILLE, Calif. — SLINGSHOT BIOSCIENCES, INC., the developers of synthetic cells, today announced they have extended their distribution channel through a new agreement with Chameleon Science. Chameleon Science is an innovative new company specializing in the development and distribution of emerging technologies in Life Sciences. The Chameleon team has over 25 years of experience in […]
Collaboration pairs Cytiva’s leadership in supplying end-to-end manufacturing solutions with Bayer’s strong expertise in technology and process development for complex therapeutics Action demonstrates Cytiva and Bayer’s commitment to advancing and accelerating the development of cell and gene therapies and expanding their accessibility for patients Cytiva and Bayer are teaming up to develop the first modular […]
SOUTH SAN FRANCISCO, Calif. & SEOUL, South Korea — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ildong Pharmaceutical, today announced an agreement under which Ildong will license a suite of Twist VHH antibody libraries to use to discover and develop […]
BOSTON, Mass. — TetraScience, the R&D Data Cloud company, announced today that Chemaxon, a leading web-based cheminformatics and bioinformatics software provider, has joined the Tetra Partner Network to help customers dramatically increase their capacity to find and synthesize chemical compounds with overall improved property profiles. “Chemaxon is an industry leader with flexible solutions that support […]
The OncoSignature® test developed based on Acrivon’s AP3 platform is a first-of-its-kind spatial signature assay to identify patients most likely to respond to ACR-368, an advanced Phase 2 targeted oncology agent for solid cancers The OncoSignature® test will run on Akoya’s PhenoImager™ Solution MARLBOROUGH, Mass. and WATERTOWN, Mass. — Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company®, […]
EMERYVILLE, CA — SLINGSHOT BIOSCIENCES, INC., the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Almog Diagnostic, a private company established in 1987 […]
Accelerated Technology Laboratories, Inc. (ATL), and its Monitor Plus technology partner, Elemental Machines, are excited to announce the availability of the Monitor Plus Test Drive Box, which will allow ATL customers and prospective clients to try Monitor Plus for a no-cost/no commitment 30-day evaluation in their own laboratory. This box contains preconfigured sensors for cold […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
